The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease
Inflammopharmacology · 2024-08 · 32 (4) · 2219-2233
DOI: 10.1007/s10787-024-01511-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 26.06.2024. Verfasst von Carine Smith. Beteiligte Einrichtung: Experimental Medicine Group, Department of Medicine, Stellenbosch University, Parow, South Africa. csmith@sun.ac.za. Hauptthemen laut MEDLINE: Zebrafish, Drug Discovery, Inflammation, Disease Models, Animal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stellenbosch University.
Abstract (Originalsprache)
Immune-mediated inflammatory disease (IMID) prevalence is estimated at 3–7% for Westernised populations, with annual incidence reported at almost 1 in 100 people globally. More recently, drug discovery approaches have been evolving towards more targeted therapies with an improved long-term safety profile, while the requirement for individualisation of medicine in complex conditions such as IMIDs, is acknowledged. However, existing preclinical models—such as cellular and in vivo mammalian models—are not ideal for modern drug discovery model requirements, such as real-time in vivo visualisation of drug effects, logistically feasible safety assessment over the course of a lifetime, or dynamic assessment of physiological changes during disease development. Zebrafish share high homology with humans in terms of proteins and disease-causing genes, with high conservation of physiological processes at organ, tissue, cellular and molecular level. These and other unique attributes, such as high fecundity, relative transparency and ease of genetic manipulation, positions zebrafish as the next major role player in IMID drug discovery. This review provides a brief overview of the suitability of this organism as model for human inflammatory disease and summarises the range of approaches used in zebrafish-based drug discovery research. Strengths and limitations of zebrafish as model organism, as well as important considerations in research study design, are discussed. Finally, under-utilised avenues for investigation in the IMID context are highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Medicine Group, Department of Medicine, Stellenbosch University, Parow, South Africa. csmith@sun.ac.za.
Förderung
- Stellenbosch University
Zitieren
APA
Smith, C. (2024). The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease. Inflammopharmacology, 32(4), 2219-2233. https://doi.org/10.1007/s10787-024-01511-1
Vancouver
Smith C. The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease. Inflammopharmacology. 2024;32(4):2219-2233. doi:10.1007/s10787-024-01511-1
BibTeX
@article{Smith2024,
author = {Smith, Carine},
title = {The potential of zebrafish as drug discovery research tool in immune-mediated inflammatory disease},
journal = {Inflammopharmacology},
year = {2024},
volume = {32},
number = {4},
pages = {2219--2233},
doi = {10.1007/s10787-024-01511-1}
}
EUVIMED